BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18411304)

  • 1. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.
    Coniglio SJ; Zavarella S; Symons MH
    Mol Cell Biol; 2008 Jun; 28(12):4162-72. PubMed ID: 18411304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
    Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
    Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
    Bright MD; Garner AP; Ridley AJ
    Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
    Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
    Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis.
    Bagheri-Yarmand R; Vadlamudi RK; Wang RA; Mendelsohn J; Kumar R
    J Biol Chem; 2000 Dec; 275(50):39451-7. PubMed ID: 10967114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of myosin light-chain phosphorylation by p21-activated kinase 1 in Escherichia coli invasion of human brain microvascular endothelial cells.
    Rudrabhatla RS; Sukumaran SK; Bokoch GM; Prasadarao NV
    Infect Immun; 2003 May; 71(5):2787-97. PubMed ID: 12704153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
    Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
    Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
    Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
    J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p21-activated kinase 2 (PAK2), but not PAK1, regulates contraction-stimulated skeletal muscle glucose transport.
    Møller LLV; Nielsen IL; Knudsen JR; Andersen NR; Jensen TE; Sylow L; Richter EA
    Physiol Rep; 2020 Jun; 8(12):e14460. PubMed ID: 32597567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
    Zhang Y; Wester L; He J; Geiger T; Moerkens M; Siddappa R; Helmijr JA; Timmermans MM; Look MP; van Deurzen CHM; Martens JWM; Pont C; de Graauw M; Danen EHJ; Berns EMJJ; Meerman JHN; Jansen MPHM; van de Water B
    Oncogene; 2018 Apr; 37(14):1869-1884. PubMed ID: 29353882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression.
    Wu R; Abramson AL; Symons MH; Steinberg BM
    Int J Cancer; 2010 Nov; 127(9):2230-7. PubMed ID: 20131316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK1 and PAK2 in cell metabolism regulation.
    Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
    J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
    Huynh N; Liu KH; Baldwin GS; He H
    Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
    Rider L; Oladimeji P; Diakonova M
    Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of BCR/ABL1
    Edlinger L; Berger-Becvar A; Menzl I; Hoermann G; Greiner G; Grundschober E; Bago-Horvath Z; Al-Zoughbi W; Hoefler G; Brostjan C; Gille L; Moriggl R; Spittler A; Sexl V; Hoelbl-Kovacic A
    Br J Haematol; 2017 Oct; 179(2):229-241. PubMed ID: 28707321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
    Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
    Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
    PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.